Dow Jones U.S. Pharmaceuticals Index

D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Lannett (M, US)  Pharmaceuticals
1. Lannett (M, US)   Pharmaceuticals	82		29		89		71
2. Prestige (L, US)  Pharmaceuticals
2. Prestige (L, US)   Pharmaceuticals	62		57		30		57
3. Pfizer (XXL, US)  Pharmaceuticals
3. Pfizer (XXL, US)   Pharmaceuticals	60		47		17		34
4. AbbVie (XXL, US)  Biotechnology
4. AbbVie (XXL, US)   Biotechnology	49		88		9		44
5. Phibro Animal (L, US)  Pharmaceuticals
5. Phibro Animal (L, US)   Pharmaceuticals	46		62		64		75

November 16, 2018. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Nektar (L, US)   Pharmaceuticals
1. Nektar (L, US)   Pharmaceuticals	21		100		86		89
2. Supernus Pharma (M, US)   Pharmaceuticals
2. Supernus Pharma (M, US)   Pharmaceuticals	11		88		54		100
3. AbbVie (XXL, US)   Biotechnology
3. AbbVie (XXL, US)   Biotechnology	49		88		9		44
4. Catalent (L, US)   Pharmaceuticals
4. Catalent (L, US)   Pharmaceuticals	30		78		38		89
5. Zoetis (XL, US)   Pharmaceuticals
5. Zoetis (XL, US)   Pharmaceuticals	20		75		50		88
6. Eli Lilly (XXL, US)   Pharmaceuticals
6. Eli Lilly (XXL, US)   Pharmaceuticals	6		69		23		19
7. Phibro Animal (L, US)   Pharmaceuticals
7. Phibro Animal (L, US)   Pharmaceuticals	46		62		64		75
8. Prestige (L, US)   Pharmaceuticals
8. Prestige (L, US)   Pharmaceuticals	62		57		30		57
9. Pacira BioSciences (M, US)   Pharmaceuticals
9. Pacira BioSciences (M, US)   Pharmaceuticals	2		56		31		33
10. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
10. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals	13		50		29		16

November 16, 2018. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Lannett (M, US)   Pharmaceuticals
1. Lannett (M, US)   Pharmaceuticals	82		29		89		71
2. Nektar (L, US)   Pharmaceuticals
2. Nektar (L, US)   Pharmaceuticals	21		100		86		89
3. Phibro Animal (L, US)   Pharmaceuticals
3. Phibro Animal (L, US)   Pharmaceuticals	46		62		64		75
4. Supernus Pharma (M, US)   Pharmaceuticals
4. Supernus Pharma (M, US)   Pharmaceuticals	11		88		54		100
5. Zoetis (XL, US)   Pharmaceuticals
5. Zoetis (XL, US)   Pharmaceuticals	20		75		50		88
6. Akorn (M, US)   Pharmaceuticals
6. Akorn (M, US)   Pharmaceuticals	33		1		50		29

November 16, 2018. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Supernus Pharma (M, US)   Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals	11		88		54		100
2. Nektar (L, US)   Pharmaceuticals
2. Nektar (L, US)   Pharmaceuticals	21		100		86		89
3. Catalent (L, US)   Pharmaceuticals
3. Catalent (L, US)   Pharmaceuticals	30		78		38		89
4. Zoetis (XL, US)   Pharmaceuticals
4. Zoetis (XL, US)   Pharmaceuticals	20		75		50		88
5. Phibro Animal (L, US)   Pharmaceuticals
5. Phibro Animal (L, US)   Pharmaceuticals	46		62		64		75
6. Lannett (M, US)   Pharmaceuticals
6. Lannett (M, US)   Pharmaceuticals	82		29		89		71
7. Prestige (L, US)   Pharmaceuticals
7. Prestige (L, US)   Pharmaceuticals	62		57		30		57

November 16, 2018. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

☀ This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from November 16, 2018.